TY - JOUR
T1 - Emerging anti-aging strategies – Scientific basis and efficacy
AU - Shetty, Ashok K.
AU - Kodali, Maheedhar
AU - Upadhya, Raghavendra
AU - Madhu, Leelavathi N.
N1 - Funding Information:
This work was supported by the Department of Defense grants (W81XWH-14-1-0558 and W81XWH-14-1-0572 to A.K.S.), the Department of Veterans Affairs Merit Award (I01BX000883 to A.K.S.), the Department of Veterans Affairs BLR&D Research Career Scientist award (1IK6BX003612 to A.K.S.) and an R01 grant from the National Institutes of Health - National Institute of Neurological Disorders and Stroke (NIH-NINDS R01NS106907-01 to D.J.P. and A.K.S.).
Publisher Copyright:
© 2018 Shetty AK et al.
PY - 2018
Y1 - 2018
N2 - The prevalence of age-related diseases is in an upward trend due to increased life expectancy in humans. Age-related conditions are among the leading causes of morbidity and death worldwide currently. Therefore, there is an urgent need to find apt interventions that slow down aging and reduce or postpone the incidence of debilitating age-related diseases. This review discusses the efficacy of emerging anti-aging approaches for maintaining better health in old age. There are many anti-aging strategies in development, which include procedures such as augmentation of autophagy, elimination of senescent cells, transfusion of plasma from young blood, intermittent fasting, enhancement of adult neurogenesis, physical exercise, antioxidant intake, and stem cell therapy. Multiple pre-clinical studies suggest that administration of autophagy enhancers, senolytic drugs, plasma from young blood, drugs that enhance neurogenesis and BDNF are promising approaches to sustain normal health during aging and also to postpone age-related neurodegenerative diseases such as Alzheimer’s disease. Stem cell therapy has also shown promise for improving regeneration and function of the aged or Alzheimer’s disease brain. Several of these approaches are awaiting critical appraisal in clinical trials to determine their long-term efficacy and possible adverse effects. On the other hand, procedures such as intermittent fasting, physical exercise, intake of antioxidants such as resveratrol and curcumin have shown considerable promise for improving function in aging, some of which are ready for large-scale clinical trials, as they are non-invasive, and seem to have minimal side effects. In summary, several approaches are at the forefront of becoming mainstream therapies for combating aging and postponing age-related diseases in the coming years.
AB - The prevalence of age-related diseases is in an upward trend due to increased life expectancy in humans. Age-related conditions are among the leading causes of morbidity and death worldwide currently. Therefore, there is an urgent need to find apt interventions that slow down aging and reduce or postpone the incidence of debilitating age-related diseases. This review discusses the efficacy of emerging anti-aging approaches for maintaining better health in old age. There are many anti-aging strategies in development, which include procedures such as augmentation of autophagy, elimination of senescent cells, transfusion of plasma from young blood, intermittent fasting, enhancement of adult neurogenesis, physical exercise, antioxidant intake, and stem cell therapy. Multiple pre-clinical studies suggest that administration of autophagy enhancers, senolytic drugs, plasma from young blood, drugs that enhance neurogenesis and BDNF are promising approaches to sustain normal health during aging and also to postpone age-related neurodegenerative diseases such as Alzheimer’s disease. Stem cell therapy has also shown promise for improving regeneration and function of the aged or Alzheimer’s disease brain. Several of these approaches are awaiting critical appraisal in clinical trials to determine their long-term efficacy and possible adverse effects. On the other hand, procedures such as intermittent fasting, physical exercise, intake of antioxidants such as resveratrol and curcumin have shown considerable promise for improving function in aging, some of which are ready for large-scale clinical trials, as they are non-invasive, and seem to have minimal side effects. In summary, several approaches are at the forefront of becoming mainstream therapies for combating aging and postponing age-related diseases in the coming years.
UR - http://www.scopus.com/inward/record.url?scp=85060464671&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060464671&partnerID=8YFLogxK
U2 - 10.14336/AD.2018.1026
DO - 10.14336/AD.2018.1026
M3 - Review article
AN - SCOPUS:85060464671
SN - 2152-5250
VL - 9
SP - 1165
EP - 1184
JO - Aging and Disease
JF - Aging and Disease
IS - 6
ER -